Register today
Luchtime Roundtable: An introduction to the Bionics Institute
Thank you for your interest in our Lunchtime Roundtable to learn more about research and commercialisation at the Bionics Institute.
Medical device research at the Bionics Institute often leads to commercialisation to ensure life-changing tests and treatments get into the clinic as soon as possible to benefit patients.
The Bionics Institute has set up several spin-off companies in the past six years, including DBS Tech for Parkinson’s; Epiminder for epilepsy, Neo-Bionica for medical device prototyping, and NirGenie for infant hearing, and there are many more in the pipeline for conditions including: age related hearing loss, chronic pain, and balance disorders such as vertigo or Meniere’s disease.
What: Lunchtime Roundtable: An introduction to the Bionics Institute
When: 27 February from 1.00-2.30pm
Where: KPMG – Tower Two, Level 36/727 Collins St, Docklands VIC 3008 – Room 21
RSVP: Before 22 February via the form below
Sponsor: The Bionics Institute would like to thank KPMG for kindly hosting this event.
In this presentation, you will hear about funding mechanisms, including a new opportunity unique to Bionics Institute that utilises PAF and PuAF structures (private and public ancillary funds) to optimise support of high-impact Australian research leading to commercialisation.
To register, please complete the form below: